A health expert has explained how the preventive HIV drug Lenacapavir works and identified the categories of individuals eligible to use it, describing it as a major step forward in efforts to reduce HIV transmission.
Speaking during an interview on Arise Television on Friday, March 13, 2026, the Manager of HIV Prevention Services, Ezinne Akinola, said the medication is designed primarily for individuals who face a substantial risk of contracting the HIV.
During the interview, the host noted the progress made in HIV prevention over the years and referenced how the disease was once widely perceived as a fatal illness. See More/Details